Current Drug Discovery Technologies

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Volume 19 , Issue 6 , 2022

This journal supports open access

Back Journal Home
Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

0 Disease(s)

Aims & Scope

Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing original research papers, reviews, drug clinical trial studies and guest edited thematic issues describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.

Current Drug Discovery Technologies is an essential journal for all scientists and research managers involved in drug discovery who wish to keep abreast of all the modern techniques and technologies used in drug discovery.

Abstracted/Indexed in


BIOSIS, British Library, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, ERA 2018, Genamics JournalSeek, Google Scholar, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory

Journal History

Current Drug Discovery Technologies Journal was launched in 2004. Dr. Vladimir P. Torchilin serves as the Editor-in-Chief of the journal.

COPE COMPLIANT
New eBook
Primary MATLAB® for Life Sciences: Guide for Beginners
You can view the contents of this
eBook [here] .
Endorsement(s)

"Modern drug discovery is increasingly driven by scientific integration, the ability to pull together seemingly unrelated branches of basic and applied sciences to produce in a timely fashion innovative and efficacious solutions to multidisciplinary human health problems. The editorial staff is to be congratulated for providing a superb forum for publishing such science and the many and varied new directions that challenge how we think about and address drug discovery."

Paul A. Wender
Stanford University, USA

Authors' Comments

I would like to express my sincere thanks for the services by Bentham Science. I'm really happy with my submission in your Journal and hope that I will able to continue submitting manuscripts to your journal. 

Saeed Samarghandian
(Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran ) 


Has contributed:  Anti-Carcinogenic Effects of Carnosol-An Updated Review

© 2022 Bentham Science Publishers | Privacy Policy